Aneurysmal subarachnoid hemorrhage (aSAH) is a medical emergency that accounts for
5% of all stroke cases. Individuals affected are typically in the prime of their lives (mean age …

Aneurysmal subarachnoid hemorrhage (aSAH) continues to be associated with significant
morbidity and mortality despite advances in care and aneurysm treatment strategies …

The management of patients with aneurysmal subarachnoid haemorrhage demands
expertise to anticipate, recognise, and promptly treat the many neurological and systemic …

The hypothesis that the cerebral microcirculation has to be involved in posthemorrhagic
cerebral ischemia was based on experimental studies showing that acutely following SAH …

Background and Purpose: Subarachnoid hemorrhage (SAH) is associated with acute and
delayed cerebral ischemia resulting in high acute mortality and severe chronic neurological …

Background Severe cerebral vasospasm is a major cause of death and disability in patients
with aneurysmal subarachnoid hemorrhage. No causative treatment is yet available and …

Cerebral vasospasm is a major source of morbidity and mortality in patients with aneurysmal
subarachnoid hemorrhage (aSAH). Evidence suggests a multifactorial etiology and this …

Subarachnoid hemorrhage after the rupture of a cerebral aneurysm is the cause of 6% to 8%
of all cerebrovascular accidents involving 10 of 100,000 people each year. Despite effective …

Aneurysmal subarachnoid hemorrhage (aSAH) is responsible for 5% to 10% of all strokes in
the United States annually and is a neurologic emergency with considerable morbidity and …

Vasospasm and delayed cerebral ischemia remain to be the common causes of increased
morbidity and mortality after aneurysmal subarachnoid hemorrhage. The majority of clinical …